These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10798014)

  • 1. FDA clears tuberculosis drug for marketing.
    Indian J Med Sci; 1999 Mar; 53(3):135-6. PubMed ID: 10798014
    [No Abstract]   [Full Text] [Related]  

  • 2. Older antibiotic gains new respect as potent treatment for tuberculosis. Rifapentine is already approved for use with humans.
    Nuermberger E
    Home Healthc Nurse; 2008 Apr; 26(4):204-5. PubMed ID: 18408506
    [No Abstract]   [Full Text] [Related]  

  • 3. Rifapentine.
    Tuberculosis (Edinb); 2008 Mar; 88(2):155-8. PubMed ID: 18486059
    [No Abstract]   [Full Text] [Related]  

  • 4. Rifampin.
    Tuberculosis (Edinb); 2008 Mar; 88(2):151-4. PubMed ID: 18486058
    [No Abstract]   [Full Text] [Related]  

  • 5. Comment on: The potential use of rifabutin for treatment of patients diagnosed with rifampicin-resistant tuberculosis.
    Akkerman OW; Alffenaar JWC
    J Antimicrob Chemother; 2019 Mar; 74(3):834. PubMed ID: 30508093
    [No Abstract]   [Full Text] [Related]  

  • 6. Rifampin.
    Alsayyed B
    Pediatr Rev; 2004 Jun; 25(6):216-7. PubMed ID: 15173456
    [No Abstract]   [Full Text] [Related]  

  • 7. From the Centers for Disease Control and Prevention. Clinical update: impact of HIV protease inhibitors on the treatment of HIV-infected tuberculosis patients with rifampin.
    JAMA; 1996 Nov; 276(19):1546. PubMed ID: 8918842
    [No Abstract]   [Full Text] [Related]  

  • 8. [Molecular medicine and treatment of tuberculosis].
    Perel'man MI; Khomiakov IuN; Kiselev VI; Severin ES; Pal'tsev MA
    Probl Tuberk; 2001; (5):5-7. PubMed ID: 11588966
    [No Abstract]   [Full Text] [Related]  

  • 9. FDA approves rifapentine for the treatment of pulmonary tuberculosis.... Food and Drug Administration.
    Roehr B
    J Int Assoc Physicians AIDS Care; 1998 Aug; 4(8):19-25. PubMed ID: 11365728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycobacterium tuberculosis and rifampin resistance, United Kingdom.
    Sam IC; Drobniewski F; More P; Kemp M; Brown T
    Emerg Infect Dis; 2006 May; 12(5):752-9. PubMed ID: 16704831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Considering the role of four months of rifampin in the treatment of latent tuberculosis infection.
    Reichman LB; Lardizabal A; Hayden CH
    Am J Respir Crit Care Med; 2004 Oct; 170(8):832-5. PubMed ID: 15297274
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug resistance in tuberculosis.
    Ebrahim GJ
    J Trop Pediatr; 2007 Jun; 53(3):147-9. PubMed ID: 17526511
    [No Abstract]   [Full Text] [Related]  

  • 13. Detecting drug-resistant tuberculosis: beacons in the dark.
    Bialy H
    Nat Biotechnol; 1998 Apr; 16(4):331. PubMed ID: 9555717
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical update: impact of HIV protease inhibitors on the treatment of HIV-infected tuberculosis patients with rifampin.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1996 Oct; 45(42):921-5. PubMed ID: 8927017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rifapentine: its role in the treatment of tuberculosis.
    Temple ME; Nahata MC
    Ann Pharmacother; 1999 Nov; 33(11):1203-10. PubMed ID: 10573321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FDA approves tuberculosis drug.
    Josefson D
    BMJ; 1998 Jul; 317(7150):11. PubMed ID: 9705629
    [No Abstract]   [Full Text] [Related]  

  • 17. From the Food and Drug Administration.
    Nightingale SL
    JAMA; 1994 Aug; 272(5):344. PubMed ID: 8028152
    [No Abstract]   [Full Text] [Related]  

  • 18. Rifapentine access in Europe: growing concerns over key tuberculosis treatment component.
    Guglielmetti L; Günther G; Leu C; Cirillo D; Duarte R; Garcia-Basteiro AL; Goletti D; Jankovic M; Kuksa L; Maurer FP; Méchaï F; Tiberi S; van Leth F; Veziris N; Lange C; ;
    Eur Respir J; 2022 May; 59(5):. PubMed ID: 35589114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Childhood tuberculosis in the United States: shifting the focus to prevention.
    Cruz AT; Martinez BJ
    Int J Tuberc Lung Dis; 2015 Dec; 19 Suppl 1():50-53. PubMed ID: 26564542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of tuberculosis.
    Fantry LE
    N Engl J Med; 2001 Nov; 345(20):1501-2. PubMed ID: 11794208
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.